The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s macroglobulinemia (WM) – a rare indol

Showing 1 posts of 1 posts found.

The Gateway to Local Adoption Series

Latest content